Cryptococcosis: Identification of Risk Areas in the Brazilian Amazon.
cryptococcosis
epidemiological profiles
spatial analysis
time-series studies
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
13 Jul 2022
13 Jul 2022
Historique:
received:
30
05
2022
revised:
26
06
2022
accepted:
05
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
The Brazilian Amazon has a specific epidemiological profile for cryptococcosis, considering its social and economic inequality, health reality, and low access to health services. Furthermore, Brazil and Colombia have the highest cryptococcosis incidence rates in Latin America. In this study, we identified the areas of risk for cryptococcosis in the state of Pará in the Brazilian Amazon. This was an ecological study of patients admitted to a referral hospital from 2008 to 2018, aged 13 years or older, and of both sexes. The spatial distribution was determined using ArcGis 10.3.1 software. Cryptococcosis was confirmed in 272 cases. The incidence rate was 3.41 cases/100,000 inhabitants. Spatial distribution was concentrated in the Metropolitana de Belém, Nordeste Paraense, and Marajó mesoregions. The sociodemographic profile consisted of 62% men, aged between 24 and 34 years (36%), without completed secondary education (64.7%), and with occupations varying between agricultural activities (13.8%) and household activities (22%). The mean hospitalization time was 39 days; the prevalent clinical form was neurological (89.7%). The mortality rate among patients with cryptococcosis was up to 40%. Knowledge of the real magnitude of the disease in the Brazilian Amazon makes it possible to identify areas with the greatest risks and to propose control and epidemiological surveillance programs.
Identifiants
pubmed: 35889130
pii: microorganisms10071411
doi: 10.3390/microorganisms10071411
pmc: PMC9324227
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Front Vet Sci. 2018 Feb 12;5:14
pubmed: 29484301
KN J Cartogr Geogr Inf. 2020;70(4):155-161
pubmed: 33134849
Mycoses. 2016 Mar;59(3):145-50
pubmed: 26691607
Scientifica (Cairo). 2013;2013:675213
pubmed: 24278784
Mem Inst Oswaldo Cruz. 2018;113(7):e170554
pubmed: 29641639
BMC Infect Dis. 2021 Oct 8;21(1):1043
pubmed: 34625036
Braz J Microbiol. 2021 Mar;52(1):279-288
pubmed: 33025379
Rev Inst Med Trop Sao Paulo. 2017 Apr 13;59:e13
pubmed: 28423088
Antimicrob Agents Chemother. 2015 Dec;59(12):7224-31
pubmed: 26349818
J Clin Microbiol. 2019 Jan 2;57(1):
pubmed: 30257903
Cad Saude Publica. 2008 Nov;24(11):2582-92
pubmed: 19009138
Lancet Infect Dis. 2017 Aug;17(8):873-881
pubmed: 28483415
Clin Infect Dis. 2019 May 30;68(12):2094-2098
pubmed: 30256903
Acta Trop. 2019 Sep;197:105023
pubmed: 31181189
Emerg Infect Dis. 2010 Feb;16(2):251-7
pubmed: 20113555
N Engl J Med. 2018 Mar 15;378(11):1004-1017
pubmed: 29539274
Rev Soc Bras Med Trop. 2021 Sep 06;54:e01692021
pubmed: 34495255
PLoS Negl Trop Dis. 2019 Jul 29;13(7):e0007569
pubmed: 31356603
Clin Infect Dis. 2017 Nov 29;65(12):2126-2129
pubmed: 29020172